106 related articles for article (PubMed ID: 17087095)
1. The immunomodulatory effect of antibiotics on the secretion of tumour necrosis factor alpha by peripheral blood mononuclear cells in response to Stenotrophomonas maltophilia stimulation.
Vickers IE; Smikle MF
West Indian Med J; 2006 Jun; 55(3):138-41. PubMed ID: 17087095
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
3. Discrepancies between various methods in susceptibility testing and epidemiological analysis of Stenotrophomonas maltophilia clinical isolates.
Masgala A; Galani I; Souli M; Giamarellou H
Cent Eur J Public Health; 2010 Jun; 18(2):119-23. PubMed ID: 20939265
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
Çıkman A; Parlak M; Bayram Y; Güdücüoğlu H; Berktaş M
Afr Health Sci; 2016 Mar; 16(1):149-52. PubMed ID: 27358626
[TBL] [Abstract][Full Text] [Related]
5. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime.
Di Bonaventura G; Spedicato I; D'Antonio D; Robuffo I; Piccolomini R
Antimicrob Agents Chemother; 2004 Jan; 48(1):151-60. PubMed ID: 14693533
[TBL] [Abstract][Full Text] [Related]
6. Influence of an extended incubation period on values of minimum inhibitory concentrations of antibiotics in Stenotrophomonas maltophilia clinical strains.
Hejnar P; Hamal P; Koukalová D
New Microbiol; 2000 Oct; 23(4):415-21. PubMed ID: 11061630
[TBL] [Abstract][Full Text] [Related]
7. In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates.
Karamanlıoğlu D; Dizbay M
Turk J Med Sci; 2019 Apr; 49(2):683-686. PubMed ID: 30866602
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
9. Effect of antimicrobials on
Santos Carvalhais BE; Souza E Silva C; Dos Santos KV
Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
[No Abstract] [Full Text] [Related]
10. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump.
Al-Hamad A; Burnie J; Upton M
Can J Microbiol; 2011 Oct; 57(10):820-8. PubMed ID: 21942332
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum bactericidal activity of ceftazidime, ciprofloxacin and meropenem against Stenotrophomonas maltophilia.
Lemmen SW; Häfner H; Reinert RR; Zolldann D; Kümmerer K; Lütticken R
J Antimicrob Chemother; 2001 Jan; 47(1):118-20. PubMed ID: 11152445
[No Abstract] [Full Text] [Related]
14. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
Köseoğlu O; Sener B; Gür D
Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
[TBL] [Abstract][Full Text] [Related]
15. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.
Poulos CD; Matsumura SO; Willey BM; Low DE; McGeer A
Antimicrob Agents Chemother; 1995 Oct; 39(10):2220-3. PubMed ID: 8619571
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations.
Krueger TS; Clark EA; Nix DE
Diagn Microbiol Infect Dis; 2001; 41(1-2):71-8. PubMed ID: 11687317
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
[TBL] [Abstract][Full Text] [Related]
20. The efflux pump SmeDEF contributes to trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia.
Sánchez MB; Martínez JL
Antimicrob Agents Chemother; 2015 Jul; 59(7):4347-8. PubMed ID: 25918144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
